Efficacy of Vitamin D on Chronic Heart Failure Among Adults
A Meta-analysis of Randomized Controlled Trials
Abstract
Abstract. Vitamin D deficiency commonly occurs in chronic heart failure. Whether additional vitamin D supplementation can be beneficial to adults with chronic heart failure remains unclear. We conducted a meta-analysis to derive a more precise estimation. PubMed, Embase, and Cochrane databases were searched on September 8, 2016. Seven randomized controlled trials that investigated the effects of vitamin D on cardiovascular outcomes in adults with chronic heart failure, and comprised 592 patients, were included in the analysis. Compared to placebo, vitamin D, at doses ranging from 2,000 IU/day to 50,000 IU/week, could not improve left ventricular ejection fraction (Weighted mean difference, WMD = 3.31, 95% confidence interval, CL = −0.93 to 7.55, P < 0.001, I2 = 92.1%); it also exerts no beneficial effects on the 6 minute walk distance (WMD = 18.84, 95% CL = −24.85 to 62.52, P = 0.276, I2 = 22.4%) and natriuretic peptide (Standardized mean difference, SMD = −0.39, 95% confidence interval CL = −0.48 to 0.69, P < 0.001, I2 = 92.4%). However, a dose-response analysis from two studies demonstrated an improved left ventricular ejection fraction with vitamin D at a dose of 4,000 IU/day (WMD = 6.58, 95% confidence interval CL = −4.04 to 9.13, P = 0.134, I2 = 55.4%). The results showed that high dose vitamin D treatment could potentially benefit adults with chronic heart failure, but more randomized controlled trials are required to confirm this result.
References
1 (2013) Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 6, 606–619.
2 (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 18, 891–975.
3 (2007) Clinical epidemiology of heart failure. Heart. 93, 1137–1146.
4 (2010) The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure. Int J Cardiol. 144, 59–63.
5 (2011) Left ventricular reverse remodelling, long-term clinical outcome, and mode of death after cardiac resynchronization therapy. Eur J Heart Fail. 13, 43–51.
6 (2000) Cardiac remodeling–concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol. 35, 569–582.
7 (2012) Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. Am J Cardiol. 110, 834–839.
8 (2012) Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail. 14, 357–366.
9 (2009) Vitamin D and the cardiovascular system. Clin J Am Soc Nephro. 4, 1515–1522.
10 (2014) Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol. 179, 1279–1287.
11 (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 168, 1629–1637.
12 (2016) Vitamin D levels predict hospitalization and mortality in patients with heart failure. Scand Cardiovasc J. 50, 17–22.
13 (2016) Effects of vitamin D supplementation on physical activity of patients with Heart Failure. Pak J Med Sci. 32, 1430–1433.
14 (2015) Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol. 39, 56–61.
15 (2016) Effects of vitamin D on cardiac function in patients with chronic HF: The VINDICATE Study. J Am Coll Cardiol. 67, 2593–2603.
16 (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 62, 1006–1012.
17 (2006) B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation. 114, 1063–1069.
18 (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 343, d5928.
19 (2014) The effect of vitamin D on aldosterone and health status in patients with heart failure. J Card Fail. 20, 334–342.
20 (2013) A randomized controlled trial of high dose vitamin D3 in patients with heart failure. JACC Heart Fail. 1, 84–90.
21 (2014) Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial. Nutr Metab Cardiovasc Dis. 24, 861–868.
22 (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 83, 754.
23 (2013) Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J. 166, 357–364-e352.
24 (2010) The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail. 3, 195–201.
25 (2016) Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study. J Am Coll Cardiol. 67, 2593–2603.
26 (2016) Vitamin D status and mortality: meta-analysis of individual participant data confirms strong association. Int J Vitam Nutr Res. 10, 1–4.
27 (2012) Vitamin D supplementation in infants with chronic congestive heart failure. Pediatr Cardiol. 33, 713–719.
28 (2011) In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet. 378, 704–712.
29 (2015) Combined 1, 25-Dihydroxy-vitamin D and resveratrol: a novel therapeutic approach to ameliorate ischemia reperfusion-induced myocardial injury. Int J Vitam Nutr Res. 85, 174–184.
30 (2016) Vitamin D and its effects on cardiovascular diseases: a comprehensive review. Korean J Intern Med. 31, 1018–1029.
31 (2011) Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D. Am J Med Sci. 341, 113.
32 (2013) Parathyroid hormone and heart failure: novel biomarker strategy. Endocr Metab Immune Disord Drug Targets. 13, 100.
